Stephen S. Johnston
About
In The Last Decade
Stephen S. Johnston
124 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cardiology and Cardiovascular Medicine 989
- Surgery 748
- Endocrinology, Diabetes and Metabolism 510
- Oncology 336
- Epidemiology 329
Countries citing papers authored by Stephen S. Johnston
This map shows the geographic impact of Stephen S. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen S. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen S. Johnston more than expected).
Fields of papers citing papers by Stephen S. Johnston
This network shows the impact of papers produced by Stephen S. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen S. Johnston. The network helps show where Stephen S. Johnston may publish in the future.
Co-authorship network of co-authors of Stephen S. Johnston
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen S. Johnston. A scholar is included among the top collaborators of Stephen S. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen S. Johnston. Stephen S. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 0 | |
| 9 | Difference in intraocular pressure following involuntary switch from bimatoprost 0.03% to bimatoprost 0.01% in glaucoma patients. | 1 |
| 10 | Real-world treatment patterns in injection cost and frequency for ranibizumab versus aflibercept in patients with wet age-related macular degeneration: A 2-year US claims analysis | 2 |
| 11 | 1 | |
| 12 | Treatment Patterns and Associated Costs of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration | 2 |
| 13 | Comparison between guideline-preferred and nonpreferred first-line HIV antiretroviral therapy. | 3 |
| 14 | Continuous Wear Non-Invasive Device for Sustained Ocular Drug Delivery | 3 |
| 15 | Sustained Delivery of Prostaglandin from Drug-Containing Depots Using Ocular Rings in Beagles | 4 |
| 16 | 31 | |
| 17 | 15 | |
| 18 | Employees' willingness to pay to prevent influenza. | 10 |
| 19 | 57 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.